Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Exelixis Inc (NASDAQ: EXEL) closed the day trading at $32.38 down -5.13% from the previous closing price of $34.13. In other words, the price has decreased by -$5.13 from its previous closing price. On the day, 3.63 million shares were traded. EXEL stock price reached its highest trading level at $33.59 during the session, while it also had its lowest trading level at $31.9.
Ratios:
For a better understanding of EXEL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.37. For the most recent quarter (mrq), Quick Ratio is recorded 3.88 and its Current Ratio is at 3.93. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
On December 20, 2024, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform and also upped its target price recommendation from $36 to $40.
BofA Securities Downgraded its Buy to Neutral on December 17, 2024, whereas the target price for the stock was revised from $35 to $39.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 29 ’24 when Hessekiel Jeffrey sold 60,000 shares for $36.67 per share. The transaction valued at 2,200,200 led to the insider holds 486,059 shares of the business.
JEFFREY HESSEKIEL bought 60,000 shares of EXEL for $2,200,230 on Nov 29 ’24. On Nov 22 ’24, another insider, Haley Patrick J., who serves as the EVP, Commercial of the company, sold 10,000 shares for $35.27 each. As a result, the insider received 352,700 and left with 278,665 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 9247048704 and an Enterprise Value of 8252332544. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.63, and their Forward P/E ratio for the next fiscal year is 16.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.44 while its Price-to-Book (P/B) ratio in mrq is 4.07. Its current Enterprise Value per Revenue stands at 3.964 whereas that against EBITDA is 12.976.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.53, which has changed by 0.4792143 over the last 52 weeks, in comparison to a change of 0.23809385 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $37.59, while it has fallen to a 52-week low of $20.01. The 50-Day Moving Average of the stock is -7.31%, while the 200-Day Moving Average is calculated to be 18.90%.
Shares Statistics:
Over the past 3-months, EXEL traded about 2.33M shares per day on average, while over the past 10 days, EXEL traded about 3245870 shares per day. A total of 285.78M shares are outstanding, with a floating share count of 277.78M. Insiders hold about 2.73% of the company’s shares, while institutions hold 87.70% stake in the company. Shares short for EXEL as of 1735603200 were 10450134 with a Short Ratio of 4.49, compared to 1732838400 on 8357534. Therefore, it implies a Short% of Shares Outstanding of 10450134 and a Short% of Float of 4.9200002.
